Roche Holding AG

Roche Holding AG: Carbon Emissions and Climate Commitments

Roche Holding AG, a pharmaceutical preparation manufacturer headquartered in CH, has established ambitious targets for reducing its environmental impact. The company is committed to achieving net-zero greenhouse gas emissions across its entire value chain by 2045.

Emissions Data:

• 2025: Roche reported total emissions of approximately 425,904,000 kg CO2e. This includes Scope 1 emissions of approximately 211,962,000 kg CO2e and Scope 2 emissions (market-based) of approximately 8,529,000 kg CO2e. Scope 3 emissions accounted for a significant portion, with purchased goods and services being the largest contributor at approximately 3,824,588,000 kg CO2e.
• 2024: Total emissions were approximately 768,986,000 kg CO2e. Scope 1 emissions were approximately 245,832,000 kg CO2e, and Scope 2 emissions (market-based) were approximately 69,198,000 kg CO2e. The largest Scope 3 category was purchased goods and services, at approximately 3,900,865,000 kg CO2e.
• 2023: Total emissions were approximately 6,521,754,000 kg CO2e. Scope 1 emissions were approximately 240,266,000 kg CO2e, and Scope 2 emissions were approximately 98,480,000 kg CO2e. Scope 3 emissions, primarily driven by purchased goods and services at approximately 4,525,396,000 kg CO2e, contributed the most significantly.
• 2022: Total emissions reached approximately 6,800,117,000 kg CO2e. Scope 1 emissions were approximately 249,350,000 kg CO2e, and Scope 2 emissions were approximately 114,452,000 kg CO2e. Scope 3 emissions, with purchased goods and services at approximately 4,866,106,000 kg CO2e, were the dominant source.
• 2021: Roche disclosed Scope 3 emissions totalling approximately 7,566,777,000 kg CO2e, with purchased goods and services being the largest contributor at approximately 6,795,889,000 kg CO2e. Scope 1 and Scope 2 data were not reported for this year.
• 2020: Scope 2 emissions were approximately 189,003,000 kg CO2e, and Scope 3 business travel emissions were approximately 56,937,000 kg CO2e. Scope 1 emissions were not reported.
• 2019 & 2018: Scope 2 emissions were approximately 195,766,000 kg CO2e and 263,973,000 kg CO2e respectively. Business travel was a notable Scope 3 category, with emissions of approximately 201,522,000 kg CO2e in 2018 and 201,522,000 kg CO2e in 2019. Scope 1 emissions were not reported.
• 2017: Scope 2 emissions were approximately 270,123,000 kg CO2e, with Scope 3 business travel at approximately 203,814,000 kg CO2e. Scope 1 emissions were not reported.
• 2016: Scope 1 emissions were approximately 326,001,000 kg CO2e, and Scope 2 market-based emissions were approximately 320,860,000 kg CO2e. Scope 3 business travel emissions were approximately 209,660,000 kg CO2e. Purchased goods and services were not fully disclosed.
• 2015: Scope 1 emissions were not reported. Scope 2 market-based emissions were approximately 322,046,000 kg CO2e, and Scope 3 business travel was approximately 204,179,000 kg CO2e.
• 2014: Scope 1 emissions were approximately 362,582,000 kg CO2e, and Scope 2 market-based emissions were approximately 376,159,000 kg CO2e. Scope 3 business travel was approximately 189,714,000 kg CO2e.
• 2013: Scope 1 emissions were approximately 403,136,000 kg CO2e, and Scope 2 market-based emissions were approximately 418,214,000 kg CO2e. Scope 3 business travel was approximately 188,924,000 kg CO2e.
• 2012: Scope 1 emissions were approximately 388,061,000 kg CO2e, and Scope 2 emissions were approximately 432,103,000 kg CO2e. Scope 3 business travel was approximately 177,678,000 kg CO2e.
• 2011: Scope 1 emissions were approximately 419,306,000 kg CO2e, and Scope 2 emissions were approximately 443,583,000 kg CO2e. Scope 3 business travel was approximately 160,632,000 kg CO2e.

Climate Commitments and Reduction Targets:

Roche is committed to significant emissions reductions across its operations and value chain.

• Net-Zero by 2045: Roche aims to achieve net-zero greenhouse gas emissions across scopes 1, 2, and 3 by 2045. This long-term goal is aligned with the Science Based Targets initiative (SBTi).
• Near-Term Scope 1 & 2 Reduction: The company has committed to reducing absolute Scope 1 and 2 greenhouse gas emissions by 70% by 2029, using 2022 as a base year.
• Near-Term Scope 3 Reduction: For Scope 3 emissions, Roche is targeting a 22.5% reduction by 2029 from a 2022 base year for specific categories including fuel- and energy-related activities, waste generated in operations, and business travel. Additionally, a 22.5% reduction is targeted for emissions from the use of sold products and end-of-life treatment of sold products within the same timeframe.
• Supplier Engagement: Roche also aims to ensure that 70% of its suppliers, representing purchased goods and services, capital goods, and upstream transportation and distribution, will have science-based targets by 2029.
• Energy Efficiency (Historical Target): A mid-term goal was to reduce consumed energy from Scope 1 and Scope 2 sources per employee by 15% within its own facilities by 2025, based on 2015 levels.